<h1>Pharma Giant in Bengaluru Accused of Rs. 300 Crore Tax Evasion and Unethical Practices in Global Operations.</h1> The Income Tax Department conducted search and seizure operations on a prominent pharmaceutical group based in Bengaluru on July 6, 2022. The group, operating in over 50 countries, was found to engage in unethical practices by offering freebies to medical professionals to promote its products, with the estimated value of these incentives around Rs. 1000 crore. Additionally, the group allegedly inflated deductions and evaded taxes, with an estimated tax evasion of over Rs. 300 crore. Violations of tax deduction provisions and unaccounted assets, including cash and jewelry, were also discovered. Further investigations are ongoing.